New Zealand Medical Device Regulatory Authority

MEDSAFE (Medicines and Medical Devices Safety Authority) is the New Zealand government agency responsible for regulating and managing medical devices and other medical products. The agency is responsible for the registration review, regulation development, and market surveillance of medical products in New Zealand.

Regulatory Authority Website:https://medsafe.govt.nz/devices/devices-landing.asp

Regulatory Framework

Medicines Act 1981

Medicines Regulations 1984

Risk Classification of Medical Devices and IVD Products

New Zealand regulations follow the principles of the Global Harmonization Task Force (GHTF), classifying medical devices into five risk classes and two subclasses. These classifications are based on the potential risks associated with the use of medical devices in accordance with the manufacturer’s intended use. The classes are outlined below:

1742204308882096.png

Market Access Requirements

ISO 13485
Technical Documentation: Manufacturers must submit comprehensive technical documentation, including product specifications, quality standards, manufacturing processes, and risk assessment reports, to demonstrate the product’s safety and effectiveness.

Medical devices must have a GMDN code

New Zealand Sponsor

A Sponsor is an entity located in New Zealand that bears legal responsibility for medical devices supplied to New Zealand, including importers, exporters, or local manufacturers. Their responsibilities include ensuring that medical devices are registered in the WAND database in accordance with regulatory requirements.
Based on the above definition, the Sponsor must meet the following criteria:
  • The Sponsor must be located in New Zealand and have a local entity (a company registered in New Zealand or a principal place of business)
  • The Sponsor must be engaged in the import, export, or manufacture of medical devices in New Zealand
  • The Sponsor may commission a local third party in New Zealand to manufacture medical devices for supply to any region worldwide
  • The Sponsor may appoint an agent to import and distribute medical devices into New Zealand. In such cases, all Sponsor obligations listed below rest with the Sponsor, not the agent.
Note: The Sponsor must have a physical presence in New Zealand. An organization without a local New Zealand entity cannot act as a Sponsor.

Registration Language

English.

Registration Pathways, Processes, Timelines, and Official Fees

Registration Pathways

All medical devices must be registered in the WAND database


Registration Process

Determine product classification: Follow the classification principles established by the GHTF; the regulatory basis is the Medicines (Medical Devices Database) Regulations 2003
Designate a New Zealand sponsor: Select a New Zealand-based responsible party (Sponsor) that meets regulatory requirements to serve as the entity responsible for product compliance in the New Zealand market. Additionally, a manufacturer information registration process is required.
Compilation of Technical Documentation: Organize and compile a complete technical dossier. Key components include: product description and specifications, manufacturing information, a list of applicable industry standards, documentation demonstrating compliance with General Safety and Performance Requirements (GSPR), risk management documentation, clinical evaluation information, and statutory documents such as the Declaration of Conformity (DOC).
Submission of Registration Application: Upload the complete set of documents to the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) and submit the registration application.
Review of Application Completeness: The Sponsor conducts a formal review of the submitted application materials to confirm their completeness and compliance.
Supplemental Documentation (if applicable): If the review identifies missing or non-compliant information, relevant materials must be submitted in response to official feedback.
Technical File Evaluation: The regulatory authority conducts a comprehensive evaluation of the product’s technical specifications, safety, and efficacy, covering multiple professional dimensions such as medical device design principles, performance metrics, safety risk assessment, and ergonomics.
Clinical Evaluation: Medsafe reviews clinical trial protocols, results reports, and data analyses to verify the product’s clinical safety and efficacy.
Authorization Assessment: The regulatory authority evaluates the product’s authorization qualifications and technical support capabilities to ensure that market supply and post-market services meet compliance requirements.
Issuance of Review Results: Medsafe makes an approval decision based on all submitted materials and assessment conclusions; the outcome is either approval or rejection of registration.

Obtaining a WAND Registration Number and Maintaining Compliance: Upon approval of registration, the company will receive a WAND registration number; subsequently, it must submit annual product updates and compliance review reports to maintain the product’s registration.


Registration Timeline and Official Fees

Medsafe typically takes about one month to complete the registration of a medical device after receiving all necessary documents and information.
The registration timeline may vary depending on the product type, complexity, and other factors.

Medsafe currently does not charge any official fees.

Labeling Requirements

Under the Medicines Act 1984, medical device labeling must comply with international best practice standards. The Global Harmonization Task Force (GHTF) is an organization composed of major regulatory authorities and industry representatives dedicated to developing guidelines for the harmonization of international medical device regulatory practices. For detailed guidance documents, please consult Wiselink.

Chapter 3 FAQ

Q: Whether the WAND list has an expiration date limit?

A: In New Zealand, there is no expiration date limit on the marking list of medical devices. However, if a medical device is deemed to pose an unacceptable hazard to the public, it may be required to be withdrawn from the market.

Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.